Northridge, CALIFORNIA4 Active Studies

Plaque Psoriasis Clinical Trials in Northridge, CALIFORNIA

Find 4 actively recruiting plaque psoriasis clinical trials in Northridge, CALIFORNIA. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
3,774
Enrolling

Recruiting Plaque Psoriasis Studies in Northridge

RecruitingNorthridge, CALIFORNIANCT07116967

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

A study to evaluate the long-term safety of Deucravacitinib versus Ustekinumab in participants with psoriasis...

3,040 participants
Bristol-Myers Squibb
View Study Details
RecruitingNorthridge, CALIFORNIANCT06979453

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

The purpose of this study is to evaluate the efficacy, safety, and drug levels of Deucravacitinib (BMS-986165) in adolescent participants with moderate to severe plaque psoriasis...

366 participants
Bristol-Myers Squibb
View Study Details
RecruitingNorthridge, CALIFORNIANCT06857942

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with moderate-to-severe plaque PsO and obesity o...

200 participants
Eli Lilly and Company
View Study Details
RecruitingNorthridge, CALIFORNIANCT06425549

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis

The primary purpose of this study is to evaluate the efficacy of bimekizumab administered subcutaneously (sc) compared to active control (ustekinumab) in children and adolescents aged 6 to \<18 years ...

168 participants
UCB Biopharma SRL
View Study Details

About Plaque Psoriasis Clinical Trials in Northridge

Plaque psoriasis is the most common form of psoriasis, characterized by raised, red patches covered with silvery-white scales. It can appear anywhere on the body and affects about 80% of people with psoriasis. Treatment includes topical therapies, phototherapy, and systemic medications including biologics.

There are currently 4 plaque psoriasis clinical trials recruiting participants in Northridge, CALIFORNIA. These studies are seeking a combined 3,774 participants. Research is being sponsored by Bristol-Myers Squibb, Eli Lilly and Company, UCB Biopharma SRL. Clinical trial participation is free and participants receive study-related medical care at no cost.

Plaque Psoriasis Clinical Trials in Northridge — FAQ

Are there plaque psoriasis clinical trials in Northridge?

Yes, there are 4 plaque psoriasis clinical trials currently recruiting in Northridge, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Northridge?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Northridge research site will contact you about next steps.

Are clinical trials in Northridge free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Northridge studies also compensate for your time and travel.

What plaque psoriasis treatments are being tested?

The 4 active trials in Northridge are testing new therapies including novel drugs, biologics, and treatment approaches for plaque psoriasis.

Data updated March 2, 2026 from ClinicalTrials.gov